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A B S T R A C T
For radiation therapy, it is crucial to ensure that the delivered dose matches the planned dose. Errors in the dose
calculations done in the treatment planning system (TPS), treatment delivery errors, other software bugs or data
corruption during transfer might lead to significant differences between predicted and delivered doses. As such,
patient specific quality assurance (QA) of dose distributions, through experimental validation of individual
fields, is necessary. These measurement based approaches, however, are performed with 2D detectors, with
limited resolution and in a water phantom. Moreover, they are work intensive and often impose a bottleneck to
treatment efficiency. In this work, we investigated the potential to replace measurement-based approach with a
simulation-based patient specific QA using a Monte Carlo (MC) code as independent dose calculation engine in
combination with treatment log files. Our developed QA platform is composed of a web interface, servers and
computation scripts, and is capable to autonomously launch simulations, identify and report dosimetric in-
consistencies. To validate the beam model of independent MC engine, in-water simulations of mono-energetic
layers and 30 SOBP-type dose distributions were performed. Average Gamma passing ratio 99 ± 0.5% for
criteria 2%/2 mm was observed. To demonstrate feasibility of the proposed approach, 10 clinical cases such as
head and neck, intracranial indications and craniospinal axis, were retrospectively evaluated via the QA plat-
form. The results obtained via QA platform were compared to QA results obtained by measurement-based ap-
proach. This comparison demonstrated consistency between the methods, while the proposed approach sig-
nificantly reduced in-room time required for QA procedures.
1. Introduction
The number of proton therapy centers is further growing, permitting
the delivery of highly conformal dose distributions through the use of
pencil beam scanning (PBS) [1,2]. For a PBS treatment plan, the weight
of several thousand of pencil beams is iteratively optimized to achieve a
conformal high dose region while sparing organs at risk [3,4]. Multi-
field optimization resulting in intensity modulated proton therapy
(IMPT) plans is seen as state-of-the-art. The achievement of homo-
geneous target dose distribution with minimum and optimally balanced
normal tissue doses for IMPT plans generally leads to highly complex
in-homogeneous, per-field target dose distributions [4]. Sub-optimal
treatment plans were shown to help account for the uncertainties
during these optimizations [5].
Treatment planning systems (TPS) that calculate such plans are
complex software systems [6], which makes comprehensive testing,
commissioning and quality assurance inevitable. In addition to the
optimized fluence map, the delivery of a PBS treatment plan requires at
least two more transformations. In the first step, it needs to be con-
verted into machine readable files and in a second step, these files have
to be correctly interpreted and delivered by the treatment machine.
Both of these transformations are potential sources of errors which may
be difficult to detect, especially given the complexity of the treatment
plans.
As such, patient specific quality assurance (PSQA) of absolute dose
distributions, through experimental validation of individual fields, is
currently necessary and commonly done. Multiple experimental ap-
proaches for patient specific QA have been reported [7–10]. Excepting
few 3D measurement approaches [11], these measurement are per-
formed with 2D detectors, with limited resolution and in a solid water
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phantom. Moreover, they are work intensive and often impose a bot-
tleneck for the throughput of a treatment room, or limit the ability to
adapt a treatment plan in a timely manner.
In order to decrease the PSQA measurement beam-time, work has
been done for the use of delivery system control files (hereafter referred
to as treatment log files) instead [12–14]. Meier et al. [15] have shown
the use of log files for independent dose calculation systems, with the
intention of detecting problems or differences in TPS dose computa-
tions. In order to achieve a greater independence, the Monte Carlo dose
engine used for QA dose calculation should be based on independent
algorithms with completely separated code bases.
After each delivery, files containing details of the machine para-
meters are generated by the Proton Therapy System (PTS). Treatment
log files can either be obtained prior to the start of a treatment course
by performing a dry-run irradiation or will be generated inherently
during each delivery of a fraction. In order to apply this method suc-
cessfully, log files must contain information on the delivered spot po-
sition, dose and energy recorded. This information may then be used to
create a plan and reconstruct the dose that was actually delivered,
which then could be compared to the prescribed planning dose.
The aim of this work is to describe the implementation of a platform
for the execution of PSQA workflows, and present an extended vali-
dation of its many components. Such a platform should require minimal
human intervention, relying on automated simulations when data is
available. Also, it should be flexible enough in order to fit future ap-
plications, such as adaptive planning and 4D dose accumulation.
Initially, two workflows were designed and implemented: TPS-plan-
based QA, which uses an independent Monte Carlo engine for checking
of the TPS dose calculation; and Log-based QA, which reconstructs the
dose based on the machine logs. Dose calculation by QA platform is
performed on patient’s geometry using the planning CT.
2. Materials and methods
In order to integrate incoming data processing, computation, vi-
sualization and report, a software platform following a server-client
architecture was developed. The main building blocks of the applica-
tion are part of the OpenPATh initiative [16] created to support open-
source software applications for research in proton-therapy. Open-
source enables researchers to reuse and build upon existent code to
avoid rewriting from scratch. In addition, a multi-party contribution to
the development and usage of said applications improves the robustness
and the trustworthiness of research software for proton-therapy [17].
The open-source modules used in this research include OpenREGGUI,
Orthanc, MCsquare, and CAPTAIN and are presented in the following
subsections.
2.1. OpenREGGUI
OpenREGGUI [18] is an image processing software featuring var-
ious registration methods, filtering methods, segmentation tools and
other radiotherapy dedicated functions such as dose volume histogram
computation and others. It is a powerful application interface that helps
clinicians to monitor patient information, and to compare planned
treatments with actual measurements when running clinical studies in
research projects.
The use of OpenREGGUI requires MATLAB [19]. It offers a graphical
interface to visualize DICOM images and to operate many image pro-
cessing functions. It allows defining complex workflows that can be
triggered directly from the MATLAB command line as well. The toolkit
also provides many desired functionalities: a) a wrapper function that
formats DICOM files to the input files required by MCsquare; b) Inter-
polation of dose maps to guarantee matching grid sizes between TPS
and MCsquare dose simulations; c) Evaluation of clinical goals after
dose computation (DVH computation). In this work, such workflows
were used as data processing libraries.
2.2. Orthanc
The project known as Orthanc [20] was used as a standalone DICOM
server. What makes Orthanc a compelling choice is the fact that it
provides a comprehensive Application Programming Interface (API),
making it possible to access it from any computer language. Orthanc
receives a request for data download each time a task requires it, and
uploads the resulting data when such process finishes.
2.3. MCsquare
Monte Carlo dose recalculations were performed using MCsquare
[21]. It is an open-source fast multipurpose Monte Carlo algorithm,
optimized for exploiting massively parallel central processing unit
(CPU) architectures. Simulations were performed with 12 calculation
threads, in an Intel Xeon server with 48 processing units. The 64 GB of
RAM available are shared when multiple simulations are launched si-
multaneously, each allocating approximately 10 GB.
MCsquare was configured to run all simulations with a MC statistics
of ×1 108 particles, which is equivalent to a standard deviation between
1 and 2% calculated inside the 50% higher dose region for all clinical
plans tested. Its inputs are the DICOM files for the plan and the CT
coming from the TPS. The method described by Schneider et al. [22]
was used to convert from HU to human tissues, which includes ele-
mental composition, weights and densities. The elastic and inelastic
nuclear interactions are sampled from cross sections in the ICRU 63
report. In order to be able to compare it with the TPS dose, the dose-to-
medium exported MCsquare is later converted into dose-to-water by
applying the appropriate Stopping Power Ratio to each voxel in the
dose map [23].
MCsquare uses different algorithms, code base and physical tables
from RayStation MC. However, they were shown to have similar ac-
curacy in simulation and experimental validations [24].
2.4. CAPTAIN
The CAPTAIN project [18] was built with a series of industry
standard web technologies and is a Free and Open Source Software
(FOSS) released under the Apache 2 license. In short, CAPTAIN is an
automated workflow manager. Its main feature is the autonomous
launching of computation workflows without human intervention.
CAPTAIN is developed based on Node.js [25] technology.
Fig. 1 shows a scheme of the platform, which can be separated into
three layers:
1. The user interface composed of a web-site with access to workflow
configuration and results.
2. The servers, composed of three isolated processes: CAPTAIN main
Fig. 1. Scheme of the platform architecture, its core units (in grey) and external
components (in white).
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server including the Workflow Manager, a dedicated DICOM server
and a database server.
3. The computation layer, where a series of OpenREGGUI and Python
scripts are called in order to complete the assigned tasks. These
scripts are also responsible for launching the Monte Carlo simula-
tions.
These layers are further discussed on the subsections below.
2.4.1. Interface
The user interface with CAPTAIN server is done through its website.
It was written in Typescript and HTML5. It follows a centralized model
where the client task is only interfacing with the servers.
The home page has an index of all patients, and from each patient
entry one may configure workflow setups and preview results. Each
workflow has its dedicated configuration page, where the default
parameter values may be changed and/or new data may be uploaded.
During a treatment, as new data become available, different config-
urations might be set for the workflows.
The result page of a workflow displays a list of all calculation tasks,
their execution status, and links leading to reports. The report page has
detailed information on a workflow run, such as configuration para-
meters and result values of the calculations. DICOM objects may also be
downloaded from the report page, both from configuration and results
fields.
2.4.2. Servers
The CAPTAIN main server is responsible for the data exchange oc-
curring between clients, data storage servers and the computation
scripts, introduced below. It was generated with the Angular Full-Stack
Generator [26], is managed by Gulp.js [27] and written in javascript.
The server offers four Application Programming Interfaces (APIs) to
connect to it and act on the database (DB). These four APIs are:
• User API: entry point from the user interface to configure the user
access to the system.
• Dicom-server API: exchange of data between the CAPTAIN server
and the DICOM server Orthanc.
• patient API: entry point from the user interface that is used to access
patient data, to configure the workflows parameters.
• patientResults API: manages the access from the user-interface to
the workflow results.
Apart from the dedicated DICOM server, described at Sub-Section
2.2, a second database server is responsible for holding state informa-
tion of the platform. MongoDB [28] is a FOSS cross-platform document-
oriented database that runs on NoSQL and uses JSON-like documents.
This DB contains three collections: users, patients and results. These
collections hold documents with information on user authorization and
permissions, patient meta-data, and workflow result values or DICOM
meta-data, respectively.
It is imperative that both data servers are kept synchronized to each
other. To that end, a system of triggers and parser were implemented.
Upon the arrival of new data at the DICOM Server, a signal is sent to
CAPTAIN server requesting parsing of the received patient data. Meta-
data is extracted from the DICOM objects, and then saved as a Patient
document in the DB. These documents are lightweight structure data,
holding only descriptions and links pointing to relevant instances inside
the DICOM Server.
2.4.3. Computation
In this work, workflow denotes a complete computation chain,
starting at a set of initial parameters and finalizing at a set of result
values. The computation between these two states is divided in small
chunks, here called tasks, which perform more specific calculations.
Therefore, a workflow is the recipe of what tasks to execute, in which
order and with what parameters. It is defined by the following objects:
• Check function, which verifies if all necessary parameters are
available, and queries the DB for previously calculated results.
• List of Tasks to be performed, each completing a specific computa-
tion step on the available data.
• Task input recipe, encoding which parameters to use in each of the
corresponding tasks.
• Task output recipe, encoding which results to save from each of the
corresponding tasks.
A single task may be used by multiple workflows, which lower
complexity and increases consistency between different workflows.
Examples of implemented tasks include: the conversion of treatment log
files into a RT plan, independent dose recalculation and evaluation of
Gamma analysis between two dose maps. Each task is composed of the
following steps:
• Preparation, which creates temporary folders for computation,
queries the DICOM server for data and the DB for other input
parameters.
• Launching, responsible for the start of the computational step,
which may include multiple script launches and/or external calls.
• Exporting, which saves the output data to the DB and/or DICOM
objects to the DICOM server.
In order to function autonomously, the Workflow Manager receives
a notification when new patient data is received by the DICOM Sever.
The Manager then triggers the start of all available workflows, starting
with the Check for available data. Many of the required input parameter
are automatically set, such as the plan, structure set and dose received
from TPS. Others may be adjusted, such as gamma analysis distance and
dose tolerances.
2.5. Workflows for QA
For an envisioned automatic plan QA, two workflows were created:
(A) a TPS-plan-based patient QA and (B) a Log-based patient QA
workflow. A scheme of these workflows is showed in Fig. 2.
In (A) TPS-based plan QA, a secondary Monte Carlo dose calculation
is executed with the same plan input as the TPS but with a completely
independent implementation (using a different programming language,
different algorithms, different physical models, and with the code being
written by a different developer). Hence, this allows for a redundant
check of the treatment planning dose calculation.
In (B) Log-based plan QA, a secondary Monte Carlo dose calculation
is made, taking the field information from a different source than the
TPS. A new plan is created from treatment log files, which become
available after each beam delivery. This can be used as a consistency
check between the expected TPS calculated dose and the PTS effective
delivery dose.
In clinical routine, these workflows are foreseen to be executed
consecutively. Planning is performed with RayStation’s Monte Carlo
algorithm, which generates the original (TPS) dose map. After plan
approval in TPS, data is exported to a dedicated DICOM server that
triggers the QA workflow (A). An independent dose recalculation au-
tomatically takes place and Gamma analysis results - comparing ori-
ginal and recalculated dose maps - become available at the website.
After review, a dry-run is performed by delivering the plan in air in
order to generate treatment log files. The upload of the logs triggers the
Log-based plan QA workflow (B). A Log-based plan is reconstructed
from the retrieved treatment log files, and results become automatically
available for review.
2.5.1. Log to plan conversion
The structure and content of treatment log files are vendor specific
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or even equipment model specific, however generally treatment log
files will contain chronological list of events, which were registered by
therapy control system during the delivery of specific treatment pre-
scription, and a list of readouts that were acquired by sensors, which
are integral part of the delivery control system. Sensor readouts may
contain such information as potentiometer positions, hall probe read-
outs, set points on power supplies, charge on strips or wires of ioniza-
tion chambers, etc. Although the readouts from the sensors may not
directly be meaningful in any way to what type of prescription has been
delivered to the patient, this information may be used to recontact what
prescriptions have been delivered into clinically meaningful way. After
all, therapy control system as an input uses clinical prescription
(treatment plans), to define state of various components of the system
to achieve delivery of a specific prescription. By reversing this process
clinical prescription itself can be reconstructed based on the state of the
machine, which is indicated by the output of various built-in sensors.
Currently, the availability of such log files are subjected to specific
agreements with the manufacturer of the delivery system.
Log file interpretation script retrieves from the treatment log files a
set of spots that has been delivered during the specific session and as-
signs their position in X and Y directions at the isocenter plane by using
readouts from the strips of the in-nozzle ionization chamber, energy
based on the position of degrader wheel and MU based on readout from
the integral pads of the in-nozzle ionization chambers. Additionally, a
set of corrections, such as, virtual source-axis-distance (VSAD) and IC-
to-isocentre distance correction, temperature and pressure correction,
etc, needs to be applied.
After the content of the delivered prescription is reconstructed, it is
written into a DICOM ion plan object and log-based plan is created.
Compatibility to DICOM standard significantly eases usability of the
data for other purposes; not only being limited to the use for in-
dependent dose re-calculation within the scope of patient QA platform,
but also enables use cases like import and re-calculation in TPS, etc.
The quality of the reconstructed plan is dependent on the accuracy
of log files recorded parameters, therefore constant validation of its
performance is required. The procedure adopted for log files validation
in this work is discussed in Sub-Section 2.6.1.
2.5.2. Structures overrides
Clinical plans often have overridden structures created in the TPS.
Their main uses are: (a) cover patient support devices, (b) create re-
gions with uniform water phantoms and (c) define boundaries for dose
calculations within external contour. In order to perform accurate cal-
culations, these exceptions are handled by python scripting. It auto-
matically identifies override tags in the structure set DICOM header,
such as the presence of a Material ID in the structure description or an
Interpreted Type of ‘External’. For (a) and (b) the density of the linked
material is converted to Hounsfield Units (HU) by consulting the CT
calibration curve, then overwriting the structure space inside the CT
with its interpolated value. For (c), the volume outside the external
structure is overwritten with air. Therefore, a new CT image with all
overrides applied to it is created and then used as input for the MC
simulations.
2.5.3. Clinical goals evaluation
In clinical practice treatment plans are commonly assessed on basis
of clinical goals. Clinical goals are defined as a set of dosimetric criteria
that should be met to achieve intended clinical outcome while risks of
developing complications are maintained reasonably low. Clinical goals
usually are either defined by user in TPS and checked automatically or
are manually checked by the user during the plan review based on dose-
volume histogram (DVH).
In case of RayStation (RaySearch, Sweden) TPS, clinical goal tem-
plates can be defined in TPS and in our clinical practice they are
commonly used during plan review process. A dedicated script was
developed that can be executed in TPS on patient specific basis to ex-
tract a list of defined patient-specific clinical goals. Afterwards the list is
written in a specific format to a JSON file and may be imported into the
patient QA platform via dedicated interface. By using the imported file,
a set of clinical goals is populated in the QA platform.
This makes it possible to assess independently re-calculated dose
distribution against clinical goals in a similar way as it is done during
plan review in TPS. One of the main reasons to use clinical goals in
combination with more commonly employed Gamma analysis for as-
sessment of QA dose distribution is because often it is not exactly
Fig. 2. Schemes of the TPS- and Log-based Plan QA
workflows. Each task has its input parameters
showed on the left, and output on the right. The
outputs of one task may be linked to the input of
another inside a workflow chain, such as the
MCsquare recomputed dose map (MC2-Dose, in red)
and the log reconstructed plan (Log-Plan, in blue).
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straight forward to interpret Gamma analysis results in a clinically
meaningful way. In other words, failing pixels or voxels in Gamma
analysis cannot be easily interpreted in the sense of their clinical re-
levance. In some cases, localization of failing Gamma analysis points
may be highly important clinically. The expectation is that evaluation
of the QA dose distribution against clinical goals will help to identify
these situations, even if Gamma passing ratio, especially globally,
would not seem alarming.
2.5.4. Gamma analysis
In this study, dose distributions are compared using a 3D version of
the global Gamma analysis [29,30]. The calculations are performed by
an external Python script, which is based on the npgamma library [31].
Both reference (TPS) and evaluated (MCsquare) dose maps are Monte
Carlo simulations, which may skew passing rate evaluations due to the
statistical uncertainties [32]. For this reason, MC statistical error is kept
less than 2 % in all calculations presented here.
2.6. Validation and testing
Due to complexity of the platform an extensive testing plan was put
in place to ensure expected functionality. Testing and validation effort
may be mainly split in four sections:
2.6.1. Log recording of plan delivery
Treatment log files from QA tests were collected at the IBA proton
therapy system in the Groningen Proton Therapy Center and then used
to reconstruct the delivered plans, here called log-based plans. These
are plans from standard daily Morning QA. The plan is composed of
1580 spots, from which the recorded spot positions and MU were used
to retrospectively evaluate agreement between log content (output) and
delivery prescription (input). Following the deliveries through half a
year period provided information on the accuracy and consistency of
the delivery system. Split between the two delivery rooms, 60 log files
sets were analyzed in this manner.
Additionally, independent external measurements from standard
monthly QA procedure with a Lynx detector were used to assess the
errors during delivery. The plans consisted of 5 spots per field, deliv-
ered with energies between 70 and 225 MeV and measured in gantry
angles between 50 and 315°. Log files from these deliveries were col-
lected and analyzed. The relative position of the spots in reference to a
central spot was then calculated for measurement and log files re-
cordings.
2.6.2. Low level component testing
As introduced earlier, workflows make use of multiple lower level
computational modules in order to generate results. Performance of
such modules was tested by performing calculations under controlled
conditions, where data input is well defined and expected output is
known or can be easily predicted. Testing of this type was applied to
such modules, and the procedure varied per component:
• 3D Gamma analysis module was tested by introducing errors of
known magnitude in the synthetic dose object. For the testing pur-
pose geometrical and dose errors were introduced.
• The log to plan converter was tested in two steps: (a) by re-
constructing spot energy, position and MU and comparing it directly
to the planned ones and (b) by importing log-based DICOM plans
back into the TPS, using TPS dose engine to recalculate the dose and
comparing it to the original planned dose.
• REGGUI’s implementation of clinical goals evaluation was validated
against the planning TPS evaluation. A set of 5 plans were calculated
with both methods, and the clinical goals evaluations were grouped
into 4 categories: target volume coverage in CTV; Mean dose in
ROIs; maximum and minimum dose in ROIs above 100 cGy cutoff;
maximum and minimum dose in ROIs below 100 cGy cutoff.
2.6.3. Beam model validation
Accuracy of the independent Monte Carlo engine and quality of the
beam model are crucial to the proposed QA workflow; therefore, par-
ticular attention was paid to validation of this component. Validation of
the beam model was performed in several tests, where the complexity
of the testing method gradually increases. Initially in-water calculations
were performed for several mono-energetic layers. The energy of these
layers was varied between 70 and 225 MeV. The main objective of these
calculations was to determine range calculation accuracy in-water.
Further a set of 30 SOBP-type fields, which was a sub-set of validation
data that was earlier used for the purpose of TPS commissioning, was
calculated in water. Range of SOBP fields was varied between 32 g/cm2
and 4.1 g/cm2 and modulation - between 2 and 4 cm. SOBP calculations
performed by independent MC engine were compared to calculations
performed by clinically used TPS, which has been already commis-
sioned, by using 3D Gamma analysis with criteria of 2%/2 mm. The
Gamma analysis was performed in absolute dose procedure which is
sensitive to dose ratio discrepancies, and calculated range discrepancies
were analyzed. Eventually, an experiment using animal tissues was set
up to evaluate accuracy of MC calculations taking into account lateral
and longitudinal heterogeneities. A vacuumed pig’s head, positioned on
top of solid water slabs, was scanned on a CT. Multiple treatment fields
(SOBP and mono-energy layers) in anterior-posterior direction were
prepared and a dose plane at the depth of 3.1 mm (WET) in solid water
below the animal tissues was selected for comparison with the mea-
surements. In the proton treatment room head was aligned using CBCT
and measurements at the selected depth were performed with an io-
nization chamber array MatriXX PT (IBA dosimetry, Germany). Proton
beam measurements were performed on a pigs head phantom using one
SOBP and three mono-energetic beams with energies between 175 and
225 MeV, and an array of ionization chambers was used for measuring
2D dose distributions at different depths of 3 and 7 mm. Calculations
were performed by TPS and MCsquare dose engines with MC statistic
tuned for 0.5% uncertainty, adjusting the number of particles per plan
accordingly. Measured dose planes were compared to calculations by
using 2D Gamma analysis with the criteria of 3%/3 mm.
2.6.4. Functional workflow testing
To test the functionality of the QA platform in clinical setting 10
patient cases were evaluated by proposed QA method retrospectively.
These clinical cases included such indications as head and neck, in-
tracranial indications and cranio-spinal axis. Via functional testing full
data flow was considered: beginning with data transfer from TPS to QA
platform and ending with creation of the reports. As part of this testing
phase timing of the workflows was performed.
The gamma analysis comparison for TPS- and Log-QA workflows are
performed with an acceptance criteria of higher than 95% Passing Ratio
(2 mm/2%) calculated in the 3D volume of the dose map. The criteria
values were tuned for increasing the error sensitivity of the workflows.
For validation purposes, its results are then compared to the standard
measurement-based QA - which is currently performed with an accep-
tance criteria of higher than 95% Passing Ratio (3 mm/3%) in 2D dose
maps measured and calculated at 3 different depths per field.
3. Results
The results are laid out in increasing complexity. We start from the
validation of the log file recording consistency, followed by the vali-
dation of the MCsquare beam model and the application of our pro-
posed PSQA workflows to a set of clinical plans. Then, some of the
clinical plans are used for validation of the log to plan reconstruction
algorithm and the OpenREGGUI implementation for clinical goals
evaluation.
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3.1. Log file consistency
Log-files consistency was validated, as per Sub-Section 2.6.1. When
comparing the reconstructed spot position and MU to 60 morning QA
plans prescriptions over half a year period, the observed average spot
position error and standard deviation in X was − ±0.0339 0.380 mm,
and in Y was ±0.268 0.470 mm. The maximum accumulated MU error
over one entire delivery was 1.75 MU, which corresponds to 0.4% of the
prescribed dose (418 MU). A detailed list of the error analysis per-
formed is presented in Table 1.
When analyzing the log reconstructed spot position to measure-
ments from monthly QA plans, relative position errors were calculated.
Considering deliveries in Room 1, the average and standard deviation
in X was ±0.0373 0.221 mm and in Y was ±0.0940 0.217 mm; with a
maximum position error of 0.514 mm. In Room 2 the results were si-
milar, the average and standard deviation in X was ±0.0727 0.155 mm
and in Y was ±0.0494 0.235 mm; with a maximum position error of
0.386 mm.
3.2. Beam model validation
As discussed in Sub-Section 2.6.3, the beam model was validated via
MC-based calculations of treatment fields performed with MCsquare.
The comparison of 30 SOBPs containing ranges between 4.1 and 32 g/
cm2 and modulation between 20 and 40 mm showed a 99% ± 0.5%
Gamma passing ratio. For the full energy spectrum from 70 to 225 MeV
range discrepancy in water was<1 mm.
The dose calculation accuracy of the MC dose engine was also
evaluated using heterogeneous real animal tissues [33]. Comparisons
between 2D dose distributions from measurement and simulations with
Gamma criterion of 3%/3 mm are provided in Table 2. Gamma pass
ratios are approximately 95% or greater for all cases. Deviations are
found at high density gradient regions (soft tissue/bones and air/tissue
interfaces) and high dose gradients regions, which could be explained
by the different material tables used to convert the CT image to che-
mical compositions in the two engines. MCsquare simulations
performed with greater MC statistics ( ×1 109 particles) showed no
measurable improvement, indicating lower statistical noise compared
to other sources of uncertainties.
3.3. Workflow testing
The feasibility of the TPS-based and Log-based QA workflows was
tested against standard measurement-based QA, as referred in
SubSection 2.6.4. A comparison between measurement-based, TPS-
based and Log-based QA for 10 clinical cases, including craniospinal
axis, intracranial and head and neck cases, is summarized in Table 3. An
example of calculated dose distributions for a breast cancer case is
shown in Fig. 3.
Independent MC calculations for these cases require 15–20 min
calculation time per treatment plan. Patient specific QA according to
the proposed TPS-based and Log-based methodology requires about
10 min of in-treatment-room time per patient for log file acquisition.
That compares to 40 min in-treatment-room time per patient for mea-
surement-based QA.
3.4. Component testing with clinical plans
Some of the aforementioned clinical plans were used for the vali-
dation of CAPTAIN’s low-level components, as described in Sub-Section
2.6.2. Based on calculated DVH, no statistical meaningful differences
between the two plans are found - example showcased in Fig. 4.
The average difference between the TPS and OpenREGGUI clinical
goals evaluation is below 1% for all cases but for ROIs with low doses.
For ROIs with <100 cGy, the difference is larger yielding to approxi-
mately 15%. In particular, average dose indicators are in very good
agreement, with an average difference of 0.007%.
4. Discussion
The overall trend observed in the workflow validation is that TPS-
based plan QA showed lower Gamma pass ratios than measurement-
based QA. This is expected, since the former compares the whole 3D
dose distribution volume with CT compositions and the later relies on
2D Gamma analysis at different depths of solid-water phantoms. In
turn, the Log-based plan QA shows a Gamma analysis pass ratio mar-
ginally lower than the aforementioned cases. Since both TPS- and Log-
based plan QAs use the same dose computation procedure, the differ-
ence can be attributed to discrepancies in delivered spot position or
dose, which were recorded on the treatment log files and used during
plan reconstruction.
The automated PSQA is managed and executed from inside the
CAPTAIN server, a multipurpose and flexible platform. In order to
provide specific functionalities, it integrates with other open source
projects, such as OpenREGGUI and MCsquare. The use of these modules
was crucial to speed up development and guarantee performance,
Table 1
Comparison between log files recordings and plan prescriptions over 60 de-
liveries split between two delivery rooms. Statistics for average and standard
deviation of position and dose errors are given together with the maximum




















Accuracy comparison for TPS and MCsquare dose calculations in heterogeneous
animal tissue showing Gamma percentage pass ratios for different beam en-
ergies and depths. TPS dose maps and MCsquare dose maps are evaluated with




(γ pass ratio %)
MCsquare dose
(γ pass ratio %)
SOBP 98.2 94.9
225 MeV, 3 mm spacing 98.3 98.7
225 MeV, 7 mm spacing 97.9 98.9
200 MeV, 3 mm spacing 99.0 96.9
200 MeV, 7 mm spacing 98.0 94.6
175 MeV, 3 mm spacing 98.5 98.9
175 MeV, 7 mm spacing 99.2 98.3
Table 3
Gamma pass ratios for measurement-based plan QA, and the proposed TPS- and
Log-based plan QA.
Patient Measurement based
(γ pass ratio %)
TPS-plan recalculation
(γ pass ratio %)
Log-plan recalculation
(γ pass ratio %)
1 100 97.43 97.71
2 99.81 98.75 96.94
3 100 98.60 91.56
4 100 98.43 98.59
5 98.31 95.37 93.30
6 98.55 96.05 95.54
7 99.44 99.05 97.98
8 99.12 99.14 98.99
9 99.52 99.30 99.14
10 99.31 96.02 94.97
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however it also demands comprehensive testing of its components.
First, MCsquare beam model profile was validated by comparing si-
mulations for a wide array of SOBPs in solid water phantoms, and in
inhomogeneous animal tissue phantoms. Over a wide range of energies
and modulations, good agreement was found between MCsquare and
TPS dose distributions. Secondly, OpenREGGUI evaluation of clinical
goals was validated against the TPS evaluation method for a set of
clinical plans. The results indicate that in ROIs subjected to doses
higher than 100 cGy, the average difference between the two im-
plementations was lower than 1%. Noticeably, the discrepancies are
larger for small doses and small volumes; since different algorithms for
DVH computation are used in TPS and OpenREGGUI, processes such as
Fig. 3. Dose maps for the TPS calculated plan (left), the log-based recalculation (right) and the dose difference (center). For visualization purpose, recalculated dose
maps have been imported in TPS. The dose maps are compared with Gamma analysis (2 mm, 2%).
Fig. 4. TPS calculated dose maps: planning dose (left), log-based recalculation (right) and the dose difference (center). Isodose curves showed in color. The dose maps
are compared with Gamma analysis (2 mm, 2%).
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interpolation and voxelization play a greater role in these cases. The
evaluation of clinical goals is dependent on the approach taken for
calculation of DVHs. As there are different approaches possible, it may
introduce bias in clinical goal evaluation. Consistency of the two
methods is necessary for a complete re-evaluation of the reconstructed
plan from treatment log files, where TPS evaluation of clinical goals are
directly compared to OpenREGGUI’s.
PSQA procedures based on independent dose calculations, such as
ours, have already been introduced for PBS ion therapy in some facil-
ities [12,34,35]. The main advantages are the reduced time required for
the measurements and the high resolution 3D dose distributions pro-
vided in the patient geometry, which improves the verification proce-
dure of both the planned and delivered dose. Recently, at PSI [15], a
toolkit for independent dose calculations was developed, which allows
for dose reconstructions at several points in the treatment workflow.
Still, the implementation of such workflows in clinical environments is
restricted to few examples. Our implementation of Log-based PSQA
brings a reactive and automated platform for ease of use in clinical
workflows. Since all presented here is open source, an interested reader
should also be able to implement similar automated worflows in other
clinics.
Due to its architecture, the CAPTAIN platform is capable to be ex-
tended for other purposes that would also benefit from its modularity.
Workflows are simple computation recipes, and existing solutions are
easily refitted into workflows’ tasks. Based on fraction wise patient
information this platform could accomplish automated daily dose re-
construction and accumulation. With an automated comparison of the
accumulated dose against the expected dose, a request for adaptation
could be automatically triggered in case of deviations. A concept for
fraction-wise retrospective 4D dose reconstruction and accumulation
was recently published [36]. Within a corresponding automated
workflow in our introduced platform, supplied treatment log files,
motion records and acquired repeated 4D CTs/CBCTs would trigger a
dose reevaluation and would trigger an adaptation if significant treat-
ment quality deviations are observed, such as dose discrepancy due to
anatomical changes. We have plans to extend the platform to include
such functionality in the future. In this case, the time required for the
plan dry-run delivery and log files collection may become a hindrance
for a fast online treatment tracking. Since adaptive workflow are gen-
erally complex and labor intensive, automatizing workflows as much as
possible as proposed here will be essential for a clinical implementation
of adaptive proton therapy.
The benefit from this kind of analysis mainly depends on the ac-
curacy of the log-file values, therefore a preliminary assessment of the
uncertainty in the recorded parameters of the scanning pencil beams is
recommended. For example, Li et al. [37] have compared the planned
and recorded values with dedicated measurements, to ensure that the
monitor and the recording system work properly, and that the log-files
are accurate enough to be used for evaluating the uncertainties in the
delivered dose, caused by variations in the beam characteristics. Hen-
ceforth, similar routine machine QAs and further validation of CAP-
TAIN’s components will be necessary for the clinical realization of the
workflows here proposed.
5. Conclusions
A new PSQA workflow was developed using an automated web
platform. Low level components were validated, such as the log to plan
converter and clinical goals evaluation. MCsquare beam model was
validated in solid water and animal tissue phantoms, displaying dose
distributions comparable to others simulated by the Monte Carlo al-
gorithm available in the TPS. The proposed patient specific automated
QA shows consistency between the measurement- and Log-based QA for
a wide range of clinical plans. This supports potential replacement of
measurements with MC-based treatment plan QA in future. The use of
this platform in clinical routine has the potential of significantly
reducing the required in-treatment-room time for PSQA. Furthermore,
the implemented platform has the potential to also automatize other
clinical procedures as for example fraction wise dose reconstruction and
accumulation, which may provide input for decision support regarding
plan adaptation.
References
[1] Mohan R, Grosshans D. Proton therapy – present and future. Adv Drug Deliv Rev
2017;109:26–44. Radiotherapy for cancer: present and future.
[2] Lomax A. What will the medical physics of proton therapy look like 10 years from
now? A personal view. Med Phys 2018;45(11):e984–93.
[3] Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol
1999;44(1):185.
[4] Unkelbach J, Paganetti H. Robust proton treatment planning: physical and biolo-
gical optimization. Seminars in Radiation Oncology 2018;28(2):88–96. Proton
Radiation Therapy.
[5] Knopf AC, Lomax A. In vivoproton range verification: a review. Phys Med Biol
2013;58(15):R131–60.
[6] Saini J, Traneus E, Maes D, Regmi R, Bowen SR, Bloch C, et al. Advanced proton
beam dosimetry part I: review and performance evaluation of dose calculation al-
gorithms. Transl Lung Cancer Res 2018;7(2).
[7] Arjomandy B, Sahoo N, Ciangaru G, Zhu R, Song X, Gillin M. Verification of patient-
specific dose distributions in proton therapy using a commercial two-dimensional
ion chamber array. Med Phys 2010;37(11):5831–7.
[8] Lin L, Kang M, Solberg TD, Mertens T, Baumer C, Ainsley CG, et al. Use of a novel
two-dimensional ionization chamber array for pencil beam scanning proton therapy
beam quality assurance. J Appl Clin Med Phys 2015;16(3):270–6.
[9] Lomax AJ, Böhringer T, Bolsi A, Coray D, Emert F, Goitein G, et al. Treatment
planning and verification of proton therapy using spot scanning: initial experiences.
Med Phys 2004;31(11):3150–7.
[10] Trnková P, Bolsi A, Albertini F, Weber DC, Lomax AJ. Factors influencing the
performance of patient specific quality assurance for pencil beam scanning IMPT
fields. Med Phys 2016;43(11):5998–6008.
[11] Henkner K, Winter M, Echner G, Ackermann B, Brons S, Horn J, et al. A motorized
solid-state phantom for patient-specific dose verification in ion beam radiotherapy.
Phys Med Biol 2015;60(18):7151.
[12] Zhu X, Li Y, Mackin D, Li H, Poenisch F, Lee A, et al. Towards effective and efficient
patient-specific quality assurance for spot scanning proton therapy. Cancers
2015;06(7):631–47.
[13] Winterhalter C, Fura E, Tian Y, Aitkenhead A, Bolsi A, Dieterle M, et al. Validating a
Monte Carlo approach to absolute dose quality assurance for proton pencil beam
scanning. Phys Med Biol 2018;63(17):175001.
[14] Matter M, Nenoff L, Meier G, Weber DC, Lomax AJ, Albertini F. Alternatives to
patient specific verification measurements in proton therapy: a comparative ex-
perimental study with intentional errors. Phys Med Biol 2018;63(20):205014.
[15] Meier G, Besson R, Nanz A, Safai S, Lomax AJ. Independent dose calculations for
commissioning, quality assurance and dose reconstruction of PBS proton therapy.
Phys Med Biol 2015;60(7):2819–36.
[16] Colaborators. The OpenPATh initiative; 2016.https://openpath.software/.
[17] Colaborators. Open-source; 2019.https://opensource.org/strategic.
[18] openREGGUI consortium. Image processing open-source platform for adaptive
proton therapy in cancer treatment; 2016.https://openreggui.org/.
[19] MATLAB. The MathWorks Inc, Natick, MA, USA; 1994–2019.https://mathworks.
com/.
[20] Jodogne S. Orthanc v1.4.2; 2012–2018.https://www.orthanc-server.com.
[21] Souris K, Lee JA, Sterpin E. Fast multipurpose Monte Carlo simulation for proton
therapy using multi- and many-core CPU architectures. Med Phys
2016;43(4):1700–12.
[22] Bazalova M, Beaulieu L, Palefsky S, Verhaegen F. Correction of CT artifacts and its
influence on Monte Carlo dose calculations. Med Phys 2007;34(61):2119–32.
[23] Paganetti H. Dose to water versus dose to medium in proton beam therapy. Phys
Med Biol 2009;54(14):4399–421.
[24] Sorriaux J, Testa M, Paganetti H, de Xivry JO, Lee JA, Traneus E, et al. Experimental
assessment of proton dose calculation accuracy in inhomogeneous media. Phys Med
2017;38:10–5.
[25] Hammond S, Cantrill B. Node.js v10.11.0; 2009–2018.https://nodejs.org.
[26] contributors G. Angular Full-Stack generator v5.0.0; 2018.https://github.com/
angular-fullstack/generator-angular-fullstack.
[27] Mao J, Schmitt M, Stryjewski T, Holt CC, Lubelski W. gulp.js v4.0.0; 2013–2018.
https://github.com/gulpjs/gulp.
[28] Ittycheria D, Merriman D, Horowitz E. MongoDB v4.0.2; 2009–2018.https://www.
mongodb.com.
[29] Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation
of dose distributions. Med Phys 1998;25(5):656–61.
[30] Low DA, Dempsey JF. Evaluation of the gamma dose distribution comparison
method. Med Phys 2003;30(9):2455–64.
[31] Biggs S, contributors. npgamma; 2015–2018.https://pypi.org/project/npgamma.
[32] Graves YJ, Jia X, Jiang SB. Effect of statistical fluctuation in Monte Carlo based
photon beam dose calculation on gamma index evaluation. Phys Med Biol
2013;58(6):1839–53.
[33] Siang KNW. Validating Monte Carlo Calculations of Clinical Proton Beams in
Animal Tissue Phantoms. Rijks Universitiet Groningen; 2019.
G. Guterres Marmitt, et al. Physica Medica 70 (2020) 49–57
56
[34] Mackin D, Li Y, Taylor MB, Kerr M, Holmes C, Sahoo N, et al. Improving spot-
scanning proton therapy patient specific quality assurance with HPlusQA, a second-
check dose calculation engine. Med Phys 2013;40(12):121708.
[35] Molinelli S, Mairani A, Mirandola A, Freixas GV, Tessonnier T, Giordanengo S, et al.
Dosimetric accuracy assessment of a treatment plan verification system for scanned
proton beam radiotherapy: one-year experimental results and Monte Carlo analysis
of the involved uncertainties. Phys Med Biol 2013;58(11):3837–47.
[36] Meijers A, Jakobi A, Stützer K, Guterres Marmitt G, Both S, Langendijk JA, et al. Log
file-based dose reconstruction and accumulation for 4D adaptive pencil beam
scanned proton therapy in a clinical treatment planning system: implementation
and proof-of-concept. Med Phys 2019.
[37] Li H, Sahoo N, Poenisch F, Suzuki K, Li Y, Li X, et al. Use of treatment log files in
spot scanning proton therapy as part of patient-specific quality assurance. Med Phys
2013;40(2):021703.
G. Guterres Marmitt, et al. Physica Medica 70 (2020) 49–57
57
